Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Adamts18 (a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18) Mus musculus
Symbol: Adamts18
Name: a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18
Description: Predicted to have metal ion binding activity and metalloendopeptidase activity. Involved in negative regulation of platelet aggregation. Predicted to localize to the extracellular region. Is expressed in several structures, including alimentary system; brain; eye; lung; and male reproductive gland or organ. Orthologous to human ADAMTS18 (ADAM metallopeptidase with thrombospondin type 1 motif 18); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A; D-mannitol.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: 9630038L21; A disintegrin and metalloproteinase with thrombospondin motifs 18; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18; ADAM-TS 18; ADAM-TS18; ADAMTS-18; ADAMTS21; E130314N14Rik
Latest Assembly: GRCm38 - Mouse Genome Assembly GRCm38
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm388113,697,123 - 113,849,343 (-)NCBIGRCm38GRCm38mm10GRCm38
MGSCv378116,222,037 - 116,372,739 (-)NCBIGRCm37mm9NCBIm37
MGSCv368116,584,749 - 116,734,820 (-)NCBImm8
Celera8117,907,065 - 118,057,233 (-)NCBICelera
Cytogenetic Map8 E1NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Phenotype Annotations
References - curated
References - uncurated


Comparative Map Data
Position Markers
QTLs in Region (GRCm38)
miRNA Target Status


Nucleotide Sequences
Protein Sequences

Additional Information

External Database Links
More on Adamts18
Alliance Gene
Ensembl Gene
JBrowse: mm9 mm10
MGI Report
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1558314
Created: 2005-11-30
Species: Mus musculus
Last Modified: 2019-09-12
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.